drug

miricorilant

1 story · latest Sep 30, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Corcept Therapeutics

Timeline

Corcept's miricorilant MASLD Phase 1 study completed, University of Missouri site

Sep 30Trial updateCorcept Therapeutics miricorilant

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.